{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:43:02Z","timestamp":1772131382171,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health, Meryland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejmech.2018.03.026","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T18:59:06Z","timestamp":1520621946000},"page":"403-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity"],"prefix":"10.1016","volume":"150","author":[{"given":"Asmaa E.","family":"Kassab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab M.","family":"Gedawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.03.026_bib1","series-title":"Principles and Practice of Infectious Diseases","first-page":"2686","article-title":"Empirical therapy and prevention of infection in immunocompromised host","author":"Pizzo","year":"1995"},{"key":"10.1016\/j.ejmech.2018.03.026_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.03.026_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90510-3","article-title":"Infection in cancer patients. A continuing association","volume":"81","author":"Bodey","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2018.03.026_bib4","first-page":"757","article-title":"Inhibition of human transitional cell carcinoma in\u00a0vitro proliferation by fluoroquinolone antibiotics","volume":"155","author":"Seay","year":"1996","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib5","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2263::AID-CNCR7>3.0.CO;2-V","article-title":"The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in\u00a0vitro","volume":"80","author":"Ebisuno","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2018.03.026_bib6","first-page":"891","article-title":"Ciprofloxacin mediated cell growth inhibition, S\/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line","volume":"6","author":"Aranha","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells","volume":"86","author":"Herold","year":"2002","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2018.03.026_bib8","first-page":"207","article-title":"Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells","volume":"21","author":"El-Rayes","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib9","first-page":"196","article-title":"Comparative evaluation of antiproliferative activity and induction of apoptosis by some fluoroquinolones with a human non-small cell lung cancer cell line in culture","volume":"5","author":"Mondal","year":"2004","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejmech.2018.03.026_bib10","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0025-6196(11)64003-2","article-title":"The fluoroquinolones","volume":"74","author":"Randall","year":"1999","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejmech.2018.03.026_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00595-006-3393-4","article-title":"Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients","volume":"37","author":"Haraguchi","year":"2007","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejmech.2018.03.026_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3565(25)23666-7","article-title":"In\u00a0vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines","volume":"248","author":"Somekh","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.03.026_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jor.1100160417","article-title":"Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in\u00a0vitro","volume":"16","author":"Miclau","year":"1998","journal-title":"J.\u00a0Orthop. Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.29.6.1073","article-title":"Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts","volume":"29","author":"Hussy","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.03.026_bib15","first-page":"2818","article-title":"Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity","volume":"52","author":"Yamashita","year":"1992","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib16","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1128\/AAC.37.10.2179","article-title":"Drug features that contribute to the activity of quinolones against mammalian topoisomerases ii and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in\u00a0vitro and cytotoxic potential","volume":"37","author":"Elsea","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.03.026_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1073\/pnas.82.2.307","article-title":"Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA","author":"Shen","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2018.03.026_bib18","first-page":"1288","article-title":"Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells","volume":"167","author":"Aranha","year":"2002","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib19","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1073\/pnas.86.8.2809","article-title":"Fluorinated 4- quinolones induce hyper production of IL-2","volume":"86","author":"Riesbeck","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2018.03.026_bib20","first-page":"35","article-title":"Enhancement of Il-2 production in human lymphocytes by two new quinolone derivatives","volume":"8","author":"Zehavi-Wilner","year":"1986","journal-title":"Lymphokine Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib21","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1016\/j.bmcl.2005.07.005","article-title":"Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones","volume":"15","author":"Forroumadi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.03.026_bib22","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1016\/j.ejmech.2011.10.014","volume":"46","author":"Az\u00e9ma","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0223-5234(00)00125-2","article-title":"Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases","volume":"35","author":"Pandeyaa","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib24","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.bmc.2009.04.027","article-title":"Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin","volume":"17","author":"Abuo-Rahma","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bcp.2007.10.016","article-title":"Next generation topoisomerase I inhibitors: rationale and biomarker strategies","volume":"75","author":"Teicher","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib26","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1021\/bi900475k","article-title":"Integrin priming dynamics: mechanisms of integrin antagonist-promoted \u03b1IIb\u03b23: PAC-1 molecular recognition","volume":"48","author":"Hantgan","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.03.026_bib27","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.bmcl.2011.04.064","article-title":"Identification and synthesis of N\u2032-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase","volume":"21","author":"Liang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.03.026_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/co2001372","article-title":"Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1)","volume":"14","author":"Hsu","year":"2012","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ejmech.2018.03.026_bib29","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1021\/ja064806w","article-title":"A\u00a0pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation","volume":"128","author":"Charkoudian","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.03.026_bib30","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm900722z","article-title":"Procaspase-3 activation as an anticancer strategy: structure\u2212activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3","volume":"52","author":"Peterson","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jmb.2009.03.003","article-title":"PAC-1 activates procaspase-3 in\u00a0vitro through relief of zinc-mediated inhibition","volume":"388","author":"Peterson","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib32","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.bmc.2012.03.061","article-title":"Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives","volume":"20","author":"Zhang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejmech.2012.11.039","article-title":"Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thionequinolone-derivatives as novel anticancer agent","volume":"60","author":"Sun","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib34","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2012.46.4149","article-title":"Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer","volume":"31","author":"Fizazi","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7164\/antibiotics.24.443","article-title":"In\u00a0vitro sensitivity of mycoplasmas isolated from various animals and sewage to antibiotics and nitrofurans","volume":"24","author":"Ogata","year":"1971","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2018.03.026_bib36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s00044-016-1571-5","article-title":"Piroxicam sulfonates biology-oriented drug synthesis (BIODS), characterization and anti-nociceptive screening","volume":"25","author":"Ullah","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.ejmech.2016.11.031","article-title":"Biology-oriented drug synthesis (BIODS): in\u00a0vitro \u03b2-glucuronidase inhibitory and in silico studies on 2-(2-Methyl-5-nitro-1H-imidazole-1-yl) ethyl aryl carboxylate derivatives","volume":"125","author":"Salar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2017.07.001","article-title":"Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazole-1-yl)ethyl aryl ether derivatives, in\u00a0vitro \u03b1-amylase inhibitory activity and in silico studies","volume":"74","author":"Taha","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2018.03.026_bib39","article-title":"Quinolonecarboxylic acid derivatives and their use as bactericidal agents","author":"Petersen","year":"1984","journal-title":"Ger. Offen."},{"key":"10.1016\/j.ejmech.2018.03.026_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2018.03.026_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A\u00a0novel assay for apoptosis Flow cytometric detection of phosphatidylserine early apoptotic cells using fluorescein labelled expression on Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J.\u00a0Immunol. Meth."},{"key":"10.1016\/j.ejmech.2018.03.026_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mai.2001.117819","article-title":"How cells die: apoptosis pathways","volume":"108","author":"Zimmermann","year":"2001","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib44","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib45","first-page":"622","article-title":"The National Cancer Institute: cancer drug discovery and development program","volume":"19","author":"Grever","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the national cancer institute in\u00a0vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2018.03.026_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Meth."},{"key":"10.1016\/j.ejmech.2018.03.026_bib48","first-page":"716","article-title":"Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells","volume":"65","author":"Tolba","year":"2013","journal-title":"Int. Union Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.03.026_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic susceptibility testing by a standardized single disk method","volume":"45","author":"Bauer","year":"1966","journal-title":"Am. J. Clin. Pathol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418302691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418302691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:22:04Z","timestamp":1751476924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418302691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":49,"alternative-id":["S0223523418302691"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.026","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}